Skip left side navigation and go to content

Funding & Research

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral MD/PhD or Other Dual-Doctoral Degree Fellowship (Parent F30) (Predoctoral Students/Medical and Graduate Students)

The NHLBI is interested in supporting individual predoctoral fellowships for combined MD/PhD training in research areas relevant to the NHLBI mission.

F30 Program Announcement (PA-14-150)

NHLBI Eligibility? To be eligible, an applicant 1) must have matriculated into a dual-degree program no more than 48 months prior to the due date of the initial (-01) application; and 2) must have identified a dissertation research project and sponsor(s). Exceptions to the first eligibility criterion will be considered when the applicant has taken an official leave of absence from the dual-degree program. In addition, over the total duration of F30 support, at least 50% of the award period must be devoted to full-time graduate research training leading to the doctoral research degree.

By the time of award, the individual must be a citizen or a non-citizen national of the United States, or must have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status).

The research proposed must be directly responsive to the mission of the NHLBI. The NHLBI does not support fellowship projects primarily focused on malignancy-related research. Studies that address a mechanistic correlation between cancer (i.e. lung cancer) and primary pulmonary diseases may be considered within the mission of the NHLBI. Applications on vaccine development will be considered outside the focus of this Funding Opportunity Announcement (FOA). Applications on respiratory pathogens will be considered within the focus of this FOA if they focus on the host immune response. Other potential overlapping areas of interest shared by the NHLBI and other Institutes/Centers of the NIH include myeloproliferative and myelodysplastic disorders, hematological malignancies resulting from disruptions in hematopoiesis, and the use of hematopoietic stem cell transplantation and other cellular therapies. Therefore, applicants are strongly encouraged to contact the NHLBI before submitting an application to determine its appropriateness for this FOA and the mission of the NHLBI.

The opportunities? Mentored research training

Duration of support? Individuals may receive up to six years of aggregate Kirschstein-NRSA support at the predoctoral level for dual-degree training, including any combination of support from institutional training grants (e.g.,T32) and an individual fellowship award. Over the total duration of F30 support, at least 50% of the award period must be devoted to graduate research training leading to the doctoral research degree. However, it is not possible to have concurrent NRSA support (e.g., F30 and T32). Applicants must consider any prior NRSA predoctoral research training in determining the duration of support requested. Accurate information regarding previous Kirschstein-NRSA support must be included in the application and will be considered at the time of award.

Where? Domestic for-profit or non-profit institutions/organizations, or public or private institutions, such as universities, colleges, hospitals and laboratories, eligible agencies of the federal government, and NIH intramural laboratories. Foreign institutions are not eligible to apply.

The sponsoring institution must have staff and facilities available on site to provide a suitable environment for performing high-quality research training. The PhD phase of the program may be conducted outside the sponsoring institution, e.g. a Federal laboratory including the NIH intramural laboratories. This training, however, must be part of a combined MD/PhD program.

Applications due? April 8, August 8, and December 8 new and resubmission applications.

Before submitting an application, individuals and their mentors should explore new and existing training programs at their institution which also provide research training opportunities (e.g., F31 and T32).

Allowable Costs: This F30 award provides a stipend, funds towards tuition and fees, and an Institutional Allowance which can be used to help defray fellowship expenses such as health insurance, research supplies, equipment, books, and travel to scientific meetings. See NOT-OD-14-046 for details.

How to apply: Applications submitted in response to this Funding Opportunity Announcement (FOA) for Federal assistance must be submitted electronically through Grants.gov using the SF424 Research and Related (R&R) forms and the SF424 (R&R) Individual Fellowship Application Guide.

Page Limitations

All page limitations described in the SF424 (R&R) Application Guide and the Table of Page Limits must be followed.

Resources for F30 Individuals:

The NHLBI Website also lists training programs under the category Request for Applications/Proposals & Program Announcements and the application receipt date.

NHLBI's Division of Blood Diseases and Resources (DBDR) Program Description

NHLBI's Division of Cardiovascular Sciences (DCVS) Program Description

NHLBI's Division of Lung Diseases (DLD) Program Description

Please contact the following Program Officer below, if you have questions about this award:

Drew E. Carlson, Ph.D.
Program Director
Office of Research Training and Career Development
Division of Cardiovascular Sciences, NHLBI (responding for all NHLBI programmatic Divisions)
Rockledge II Building, Room 8142
6701 Rockledge Drive, MSC 7940
Bethesda, MD 20892-7940
Telephone: (301) 435-0535
FAX: (301) 480-7404
Email: carlsonde@nhlbi.nih.gov

Direct your questions about financial or grants management issues to:

Ms. Kimberly Stanton
Senior Grants Specialist
National Heart, Lung, and Blood Institute
6701 Rockledge Drive, Room 7152
Bethesda, MD 20892-7926 (20814 express)
Telephone: (301) 435-0159
FAX: (301) 451-5462
Email: stantonk@nhlbi.nih.gov

Revised: March 2014

Skip footer links and go to content
Twitter iconTwitterExternal link Disclaimer         Facebook iconFacebookimage of external link icon         YouTube iconYouTubeimage of external link icon         Google+ iconGoogle+image of external link icon